[go: up one dir, main page]

PL2663318T3 - Kompozycja farmaceutyczna do leczenia raka - Google Patents

Kompozycja farmaceutyczna do leczenia raka

Info

Publication number
PL2663318T3
PL2663318T3 PL12702318T PL12702318T PL2663318T3 PL 2663318 T3 PL2663318 T3 PL 2663318T3 PL 12702318 T PL12702318 T PL 12702318T PL 12702318 T PL12702318 T PL 12702318T PL 2663318 T3 PL2663318 T3 PL 2663318T3
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
treating cancer
cancer
treating
pharmaceutical
Prior art date
Application number
PL12702318T
Other languages
English (en)
Inventor
Bakulesh Mafatlal Khamar
Indravadan Ambalal Modi
Original Assignee
Cadila Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Pharmaceuticals Ltd filed Critical Cadila Pharmaceuticals Ltd
Publication of PL2663318T3 publication Critical patent/PL2663318T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/58Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/04Mycobacterium, e.g. Mycobacterium tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL12702318T 2011-01-11 2012-01-10 Kompozycja farmaceutyczna do leczenia raka PL2663318T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN92MU2011 2011-01-11
EP12702318.2A EP2663318B1 (en) 2011-01-11 2012-01-10 Pharmaceutical composition for treating cancer
PCT/IB2012/050120 WO2012095789A1 (en) 2011-01-11 2012-01-10 Pharmaceutical composition for treating cancer

Publications (1)

Publication Number Publication Date
PL2663318T3 true PL2663318T3 (pl) 2015-08-31

Family

ID=54264167

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12702318T PL2663318T3 (pl) 2011-01-11 2012-01-10 Kompozycja farmaceutyczna do leczenia raka

Country Status (10)

Country Link
US (2) US20130295648A1 (pl)
EP (1) EP2663318B1 (pl)
JP (1) JP5889335B2 (pl)
CN (1) CN103338779B (pl)
AU (1) AU2012206322B2 (pl)
CA (1) CA2824417C (pl)
ES (1) ES2536842T3 (pl)
PL (1) PL2663318T3 (pl)
RU (1) RU2580888C2 (pl)
WO (1) WO2012095789A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2580888C2 (ru) * 2011-01-11 2016-04-10 Кадила Фармасьютикалз Лимитед Фармацевтическая композиция для лечения рака
JP6421208B2 (ja) * 2017-02-28 2018-11-07 カディラ ファーマシューティカルズ リミテッド がん抗原
CN117677601A (zh) * 2021-04-12 2024-03-08 蓝腾制药公司 用于治疗肺癌和非小细胞肺癌的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA79952C2 (en) * 2001-12-10 2007-08-10 Kabulesh Mafatlal Khamar MYCOBACTERIUM w APPLICATIONS FOR CANCER TREATMENT
AU2002353366A1 (en) * 2001-12-10 2003-06-23 Bakulesh Mafatlal Khamar The process of manufacturing a pharmaceutical composition useful for management of cancer
WO2003089462A2 (en) * 2002-04-16 2003-10-30 Jun Liu Tuberculosis vaccines including recombinant bcg strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase
US20100086911A1 (en) * 2005-03-03 2010-04-08 Ryosuke Katsuyama Preventive/therapeutic agent for cancer
CA2681420A1 (en) * 2007-03-20 2008-09-25 Cadila Pharmaceuticals Limited P38 inhibitors
RU2580888C2 (ru) * 2011-01-11 2016-04-10 Кадила Фармасьютикалз Лимитед Фармацевтическая композиция для лечения рака
JP2014521599A (ja) * 2011-07-05 2014-08-28 カディラ ファーマシューティカルズ リミテッド がん抗原

Also Published As

Publication number Publication date
RU2580888C2 (ru) 2016-04-10
EP2663318A1 (en) 2013-11-20
CA2824417C (en) 2019-02-26
EP2663318B1 (en) 2015-03-18
WO2012095789A1 (en) 2012-07-19
JP5889335B2 (ja) 2016-03-22
ES2536842T3 (es) 2015-05-29
US20150290255A1 (en) 2015-10-15
US20130295648A1 (en) 2013-11-07
AU2012206322B2 (en) 2016-09-01
CN103338779B (zh) 2015-12-23
CN103338779A (zh) 2013-10-02
CA2824417A1 (en) 2012-07-19
US9415078B2 (en) 2016-08-16
AU2012206322A1 (en) 2013-08-29
JP2014502631A (ja) 2014-02-03
RU2013136780A (ru) 2015-02-20

Similar Documents

Publication Publication Date Title
HUE044611T2 (hu) Gyógyászati készítmény rák kezelésére
HUE045461T2 (hu) Gyógyászati készítmény rák kezelésére
AP3864A (en) Pharmaceutical composition
IL227429A0 (en) The components and methods of cancer treatment
PL3967315T3 (pl) Akkermansia muciniphila do leczenia nowotworu złośliwego
IL234831B (en) Medical preparations for combined treatment
GB201118232D0 (en) Pharmaceutical composition
IL228644A0 (en) Cancer treatment methods
ZA201308157B (en) Pharmaceutical composition
PL2742356T3 (pl) Środki prognostyczne w leczeniu nowotworów
EP2774917A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETES
LT2814473T (lt) Farmacinės kompozicijos, skirtos derinių terapijai
SG11201400976WA (en) Methods and pharmaceutical compositions for treating cancer
IL229231A0 (en) Preparations and methods for the treatment of cancer
ZA201503005B (en) Ingenol-derived compounds useful for treating cancer
IL232479A0 (en) Combined treatment of ovarian cancer
EP2727593A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING NICORANDIL
EP2711010A4 (en) PHARMACEUTICAL COMPOSITION
PL2663318T3 (pl) Kompozycja farmaceutyczna do leczenia raka
SI2617412T1 (sl) Sestavek za topično zdravljenje
HUP1100444A2 (en) Pharmaceutical composition
HUP1100445A2 (en) Pharmaceutical composition
EP2785343A4 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HYPERLIPIDEMIA
SG10201601715YA (en) Novel Pharmaceutical Combinations And Methods For Treating Cancer
IL213610A0 (en) Composition for treating dermatological conditions